Search results for "Positive Airway Pressure"

showing 10 items of 104 documents

Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea : data from t…

2020

Background and aim: Obstructive sleep apnea (OSA) is an independent risk factor for dyslipidemia. The current study examined the effects of positive airway pressure (PAP) treatment on lipid status in the European Sleep Apnea Database (ESADA). Methods: The prospective cohort study enrolled 1564 OSA subjects (74% male, mean age 54 ± 11y, body mass index (BMI) 32.7 ± 6.6 kg/m2 and apnea-hypopnea index (AHI) 40.3 ± 24.4 n/h) undergoing PAP therapy for at least three months (mean 377.6 ± 419.5 days). Baseline and follow-up total cholesterol (TC) from nine centers were analyzed. Repeated measures and logistic regression tests (adjusted for age, sex, weight changes, lipid lowering medication, PAP …

cardiovascular riskAdultMalemedicine.medical_specialtySettore MED/10 - Malattie Dell'Apparato RespiratorioPositive airway pressure03 medical and health sciences0302 clinical medicineInternal medicinePositive airway pressuremedicineCardiovascular risk Cholesterol Hypoxia Sleep apneaHumanspositive airway pressureProspective StudiesRisk factorProspective cohort studyHypoxiaAgedSleep Apnea ObstructiveFramingham Risk ScoreContinuous Positive Airway Pressurebusiness.industryhypoxiaSleep apneaSleep apneacholesterolGeneral MedicineMiddle Agedmedicine.diseasesleep apneaCardiovascular riskObstructive sleep apneaCardiovascular risk ; Cholesterol ; Hypoxia ; Positive airway pressure ; Sleep apnea.Cholesterol030228 respiratory systemPatient ComplianceFemaleHuman medicinebusinessBody mass index030217 neurology & neurosurgeryDyslipidemiaSleep medicine
researchProduct

Noninvasive Ventilation in Critically Ill Patients

2015

Since its first application in the late 1980s, noninvasive ventilation (NIV) has been the first-line intervention for certain forms of acute respiratory failure. NIV may be delivered through the patient's mouth, nose, or both using noninvasive intermittent positive pressure ventilation or continuous positive airway pressure. When applied appropriately, NIV may reduce morbidity and mortality and may avert iatrogenic complications and infections associated with invasive mechanical ventilation. This article provides physicians and respiratory therapists with a comprehensive, practical guideline for using NIV in critical care. © 2015 Elsevier Inc.

lung diseaseproceduremedicine.medical_treatmenttreatment indicationtreatment contraindicationReviewCritical Care and Intensive Care MedicineAcute respiratory failureintensive care unitequipment designContinuous positive airway pressureHospital MortalityRespiratory systemNoserisk reductionsleep disorderemergency health serviceRespiratory Distress Syndromeemergency wardcritical illnehumidifierGeneral Medicineadult respiratory distress syndromeIntermittent positive pressure ventilationCritically patientrespiratory circuitmedicine.anatomical_structurepriority journalpositive end expiratory pressureNoninvasive ventilationEmergency Service Hospitalmedicine.medical_specialtyventilatorCritical Illnesswardhypercapnic nonchronic obstructive pulmonary diseasecritically ill patientRespiratory Distress Syndrome Adult Critical Illneobesity hypoventilation syndromemedicineHumansAcute respiratory failurehumanIntensive care medicinelung edemaMechanical ventilationgeneral wardhypoxemiaNoninvasive Ventilationair humidificationCritically illbusiness.industrypractice guidelineRespiratory Distress Syndrome Adultneurally adjusted ventilator assistrespiratory intensive care unitmortalityacute cardiogenic pulmonary edemahypercapnic chronic obstructive pulmonary diseasedisease exacerbationnoninvasive positive pressure ventilationbusinesschronic obstructive lung diseaserespiratory therapeutic device
researchProduct

Noninvasive Continuous Positive Airway Pressure Response in Bronchiectasis Exacerbations: Key Practical Aspects and Topics

2016

Bronchiectasis is a progressive lung disease characterized by gradual airflow obstruction secondary to mucus plugging, excessive airway inflammation, and parenchymal destruction. Continuous positive airway pressure (CPAP) has been shown to promote recruitment of the flooded alveoli, decrease the ventilation-perfusion mismatch, and relieve dyspnea in patients with bronchiectasis exacerbations. It has also been proven to improve respiratory mechanics and reduce the work of breathing. It can be also successfully adopted in promoting mucus clearance and preventing desaturation during chest physiotherapy and exercise. However, validated criteria for starting CPAP treatment in bronchiectasis are …

medicine.medical_specialtyBronchiectasisbusiness.industrycpapmedicine.medical_treatmentRespiratory physiologyrespiratory systemmedicine.diseaserespiratory tract diseasesbronchiectasiWork of breathingRespiratory failureLung diseasemedicineIn patientContinuous positive airway pressureIntensive care medicinebusinessMucus clearance
researchProduct

Hypoxemia during Sleep

1988

In most normal subjects arterial oxyhemoglobin saturation (SaO2) remains substantially stable throughout all sleep time: some exceptions however, may be observed especially in elderly subjects, who may show desaturations, sometimes associated with apneas (Block et al., 1979; Krieger et al., 1983; Catterall et al., 1985). Conversely, SaO2 drops during part of, or even the whole sleep time, are a common finding in pathological conditions like obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD).

medicine.medical_specialtyCOPDbusiness.industrymedicine.medical_treatmentSleep apneamedicine.diseaseSleep in non-human animalsrespiratory tract diseasesHypoxemiaObstructive sleep apneaSleep and breathingInternal medicineCardiologyMedicineContinuous positive airway pressuremedicine.symptombusinessPathological
researchProduct

Sleep Apnea: New Insights

2004

Sleep apnea is the most common disorder of breathing during sleep. It is defined as repeated episodes of obstructive apnea and hypopnea during sleep, together with daytime sleepiness or altered cardiopulmonary function [1]. There are three syndromes of upper airway closure during sleep: obstructive sleep apnea (OSA), obstructive sleep hypopnea, and upper airway resistance. These three syndromes share two features: excessive daytime sleepiness and arousal associated with increased ventilatory effort in response to upper airway closure. The specific sites of narrowing or closure and upper airway dysfunction are influenced by the underlying neuromuscular tone, upper airway muscle synchrony, an…

medicine.medical_specialtyCentral sleep apneabusiness.industrymedicine.medical_treatmentSleep apneaExcessive daytime sleepinessmedicine.diseaseSleep in non-human animalsrespiratory tract diseasesObstructive sleep apneaAirway resistanceInternal medicinemedicineCardiologyContinuous positive airway pressuremedicine.symptombusinessHypopnea
researchProduct

Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss …

2021

Abstract: Patients with obstructive sleep apnea (OSA) are at increased risk of developing metabolic disease such as diabetes. The effects of positive airway pressure on glycemic control are contradictory. We therefore evaluated the change in glycated hemoglobin (HbA1c) in a large cohort of OSA patients after long-term treatment with positive airway pressure. HbA1c levels were assessed in a subsample of the European Sleep Apnea Database [n=1608] at baseline and at long-term follow up with positive airway pressure therapy (mean 378.9 +/- 423.0 days). In a regression analysis, treatment response was controlled for important confounders. Overall, HbA1c decreased from 5.98 +/- 1.01% to 5.93 +/- …

medicine.medical_specialtyHbA1cCognitive Neuroscience03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicinepositive airway pressure therapyWeight lossDiabetes mellitusInternal medicinePositive airway pressureWeight LossmedicinePrevalenceHumansGlycemicGlycated HemoglobinSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industrySleep apneaGeneral Medicinemedicine.diseasesleep apnearespiratory tract diseasesObesity MorbidObstructive sleep apnea030228 respiratory systemchemistryConcomitantCardiologyCpapGlycated hemoglobinHuman medicinemedicine.symptombusiness030217 neurology & neurosurgeryJournal of sleep research
researchProduct

Therapy with non-invasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype.

2009

Patients with obstructive sleep apnoea are at increased risk of atherosclerotic morbidity and mortality. Abnormalities in lipid metabolism that occur in response to chronic intermittent hypoxia in patients with sleep-disordered breathing may increase the cardiovascular risk in an already susceptible population. Atherogenic lipoprotein phenotype and small, dense LDL have an independent predictive role for future cardio- and cerebro-vascular events in patients with the metabolic syndrome. Therefore, testing the hypothesis that therapy of obstructive sleep apnoea may reduce atherogenic lipoprotein phenotype might have significant clinical implications. We suggest that abolition of obstructive …

medicine.medical_specialtyLipoproteinsmedicine.medical_treatmentmedicine.disease_causeInternal medicinemedicineHumansContinuous positive airway pressureOxygen saturation (medicine)Sleep Apnea Obstructivebusiness.industryobstructive sleep apnoea Atherogenic lipoproteinthe metabolic syndrome cardiovascular riskLipid metabolismGeneral MedicineAtherosclerosismedicine.diseaseRespiration ArtificialSleep in non-human animalsEndocrinologyCirculatory systemBreathingCardiologyMetabolic syndromebusinessaterosclerosiOxidative stress
researchProduct

Positive Airway Pressure Treatment Reduces Glycated Hemoglobin (HbA1c) Levels in Obstructive Sleep Apnea Patients: Longitudinal Data from the Esada

2019

European-Respiratory-Society (ERS) International Congress -- SEP 28-OCT 02, 2019 -- Madrid, SPAIN

medicine.medical_specialtyLongitudinal dataGastroenterologyComorbidities03 medical and health sciencesHba1c levelchemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicinePositive airway pressuremedicine030212 general & internal medicinebusiness.industryType 2 Diabetes MellitusSleep apneaSystemic effectmedicine.diseaserespiratory tract diseasesObstructive sleep apnea030228 respiratory systemApnea–hypopnea indexchemistryCardiologyGlycated hemoglobinbusinessBody mass indexTurkish Thoracic Journal
researchProduct

2018

Insomnia and obstructive sleep apnea (OSA) are often both present in patients with sleep-disordered-breathing (SDB). The coexistence of the two disorders shows an increase in cumulative morbidity and an overall greater illness severity. There is still considerable controversy regarding management decisions in this group of patients. This systematic review focused on more recent evidence regarding treatment of patients presenting with both clinical entities of comorbid insomnia and OSA (COMISA) in terms of their management, especially using combinations of positive airway pressure [PAP, namely aPAP, cPAP, adaptive servo-ventilation (ASV)] and CBTi as well as each one of these two modalities …

medicine.medical_specialtyModalitiesComorbid insomniabusiness.industrymedicine.medical_treatmentSleep apneamedicine.diseasenervous system diseasesrespiratory tract diseasesCognitive behavioral therapyObstructive sleep apnea03 medical and health sciences0302 clinical medicine030228 respiratory systemNeurologymental disordersPositive airway pressureInsomniaMedicineIn patientNeurology (clinical)medicine.symptombusinessIntensive care medicine030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Management of obstructive sleep apnea in Europe.

2011

Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services. Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example. Results: Sleep centers from 21 countries (38 physicians) participated. A broad consist…

medicine.medical_specialtyNeurologyCertificationInternationalityReferralmedicine.medical_treatmentPolysomnographyPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioSurveys and QuestionnairesPositive airway pressuremedicineHumansContinuous positive airway pressureIntensive care medicineReimbursementSleep Apnea ObstructivePublic health services sleep apnea sleep disordered breathing OSA management OSA therapy OSA reibursement OSA treatmentmedicine.diagnostic_testContinuous Positive Airway Pressurebusiness.industrySleep apneaProfessional PracticeMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREGeneral Medicinemedicine.diseaserespiratory tract diseasesObstructive sleep apneaEuropeHealth Care SurveysPublic health servicesSleep apnea Sleep disordered breathing OSA management OSA therapyOSA reimbursement OSA treatmentMedicineHuman medicinebusinessSleep medicine
researchProduct